Ask AI

Optimizing First-line Maintenance for HER2+ MBC: Equipping the Multidisciplinary Team With the Latest Evidence and Guidance on Novel Regimens

Gain expert insights into how to optimize first-line maintenance therapy for patients with HER2+ metastatic breast cancer (MBC) based on the latest evidence and recommendations through a certified on-demand webcast, ClinicalThought commentary, and downloadable slides.

Share

Program Content

Events

Activities

First Line Maintenance for HER2pos MBC
Optimizing First-line Maintenance for HER2+ MBC: Equipping the Multidisciplinary Team With the Latest Evidence and Guidance on Novel Regimens 
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: March 19, 2026

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC dba Decera Clinical Education

Supporters

Supported by an educational grant from Pfizer Inc.

Pfizer Inc.